Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot

Menopause and Risk of Cardiovascular Disease

William B. Kannel · Annals of Internal Medicine · 1976 · 1.4K citations

Medicine, Cardiology, Endocrinology +17

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.

R K Ross, Malcolm C. Pike, Martin Vessey et al. · BMJ · 1986 · 410 citations · Full text

Medicine, Gynecology, Obstetrics +15

PULSATILE SECRETION OF LH, FSH, PROLACTIN, OESTRADIOL AND PROGESTERONE DURING THE HUMAN MENSTRUAL CYCLE

Conra Backstrom, Alan S. McNeilly, Rosemary Leask et al. · Clinical Endocrinology · 1982 · 348 citations

Medicine, Endocrinology, Reproductive Biology +16

The Premenstrual Syndrome

Ken Muse, Nancy S. Cetel, Lori A. Futterman et al. · New England Journal of Medicine · 1984 · 270 citations

Medicine, Psychiatry, Psychology +15

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

André Lemay, Rodolphe Maheux, Nacia Faure et al. · Fertility and Sterility · 1984 · 213 citations

Medicine, Endocrinology, Pharmacology +16